Celldex Therapeutics shares owned by Octagon Capital Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Octagon Capital Advisors
from 13F filings
Historical chart of Octagon Capital Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Octagon Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $28M | 708k | 39.66 |
| 2023-09-30 | $21M | 760k | 27.52 |
| 2023-06-30 | $26M | 760k | 33.93 |
| 2023-03-31 | $27M | 760k | 35.98 |
| 2022-12-31 | $34M | 761k | 44.57 |
| 2022-09-30 | $21M | 761k | 28.11 |
| 2022-06-30 | $21M | 761k | 26.96 |
| 2022-03-31 | $26M | 761k | 34.06 |
| 2021-12-31 | $29M | 761k | 38.64 |
| 2021-09-30 | $41M | 761k | 53.99 |
| 2021-06-30 | $19M | 561k | 33.44 |
| 2021-03-31 | $12M | 561k | 20.60 |
| 2020-12-31 | $18M | 1.0M | 17.52 |